Tredje AP-fonden’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.2M | Buy |
117,984
+36,634
| +45% | +$3.21M | 0.05% | 325 |
|
|
2026
Q1 | $7.36M | Buy |
81,350
+55,741
| +218% | +$5.12M | 0.04% | 387 |
|
|
2025
Q4 | $2.3M | Buy |
25,609
+2,078
| +9% | +$197K | 0.02% | 278 |
|
|
2025
Q3 | $2.32M | Buy |
23,531
+7,278
| +45% | +$721K | 0.02% | 245 |
|
|
2025
Q2 | $1.48M | Hold |
16,253
| – | – | 0.01% | 292 |
|
|
2025
Q1 | $1.84M | Hold |
16,253
| – | – | 0.02% | 241 |
|
|
2024
Q4 | $1.72M | Sell |
16,253
-16,252
| -50% | -$1.74M | 0.02% | 298 |
|
|
2024
Q3 | $3.51M | Hold |
32,505
| – | – | 0.03% | 256 |
|
|
2024
Q2 | $3.53M | Buy |
32,505
+20,576
| +172% | +$2.43M | 0.03% | 241 |
|
|
2024
Q1 | $1.57M | Hold |
11,929
| – | – | 0.02% | 411 |
|
|
2023
Q4 | $1.45M | Sell |
11,929
-13,000
| -52% | -$1.45M | 0.02% | 442 |
|
|
2023
Q3 | $2.8M | Buy |
24,929
+747
| +3% | +$94.9K | 0.04% | 280 |
|
|
2023
Q2 | $3.52M | Buy |
24,182
+14,851
| +159% | +$2.02M | 0.05% | 253 |
|
|
2023
Q1 | $1.21M | Hold |
9,331
| – | – | 0.02% | 461 |
|
|
2022
Q4 | $1.19M | Sell |
9,331
-2,463
| -21% | -$286K | 0.02% | 467 |
|
|
2022
Q3 | $1.23M | Sell |
11,794
-9,982
| -46% | -$1.1M | 0.03% | 432 |
|
|
2022
Q2 | $2.29M | Hold |
21,776
| – | – | 0.06% | 221 |
|
|
2022
Q1 | $2.79M | Sell |
21,776
-653
| -3% | -$78.7K | 0.06% | 226 |
|
|
2021
Q4 | $2.77M | Buy |
22,429
+7,007
| +45% | +$917K | 0.05% | 235 |
|
|
2021
Q3 | $2.19M | Hold |
15,422
| – | – | 0.05% | 243 |
|
|
2021
Q2 | $2.41M | Hold |
15,422
| – | – | 0.05% | 168 |
|
|
2021
Q1 | $2.4M | Hold |
15,422
| – | – | 0.06% | 173 |
|
|
2020
Q4 | $2.31M | Hold |
15,422
| – | – | 0.06% | 170 |
|
|
2020
Q3 | $2.04M | Hold |
15,422
| – | – | 0.07% | 155 |
|
|
2020
Q2 | $1.79M | Hold |
15,422
| – | – | 0.07% | 150 |
|
|
2020
Q1 | $1.51M | Sell |
15,422
-5,044
| -25% | -$661K | 0.08% | 185 |
|
|
2019
Q4 | $2.98M | Sell |
20,466
-3,308
| -14% | -$457K | 0.15% | 170 |
|
|
2019
Q3 | $3.17M | Sell |
23,774
-1,340
| -5% | -$173K | 0.15% | 173 |
|
|
2019
Q2 | $2.88M | Sell |
25,114
-471
| -2% | -$55.2K | 0.14% | 192 |
|
|
2019
Q1 | $3.18M | Buy |
25,585
+5,795
| +29% | +$659K | 0.16% | 156 |
|
|
2018
Q4 | $2M | Buy |
19,790
+568
| +3% | +$63.9K | 0.12% | 194 |
|
|
2018
Q3 | $2.46M | Sell |
19,222
-18,515
| -49% | -$2.2M | 0.12% | 199 |
|
|
2018
Q2 | $4.09M | Buy |
37,737
+5,878
| +18% | +$640K | 0.14% | 199 |
|
|
2018
Q1 | $3.38M | Sell |
31,859
-2,575
| -7% | -$299K | 0.12% | 209 |
|
|
2017
Q4 | $4.04M | Buy |
34,434
+649
| +2% | +$73.4K | 0.14% | 186 |
|
|
2017
Q3 | $3.85M | Sell |
33,785
-1,144
| -3% | -$132K | 0.14% | 192 |
|
|
2017
Q2 | $4.36M | Sell |
34,929
-175
| -0.5% | -$20.7K | 0.16% | 169 |
|
|
2017
Q1 | $4.17M | Sell |
35,104
-1,436
| -4% | -$163K | 0.16% | 177 |
|
|
2016
Q4 | $3.67M | Sell |
36,540
-6,377
| -15% | -$684K | 0.16% | 182 |
|
|
2016
Q3 | $5.43M | Buy |
42,917
+3,721
| +9% | +$460K | 0.25% | 103 |
|
|
2016
Q2 | $4.59M | Buy |
39,196
+14,644
| +60% | +$1.66M | 0.21% | 107 |
|
|
2016
Q1 | $2.79M | Buy |
24,552
+21,150
| +622% | +$2.05M | 0.13% | 163 |
|
|
2015
Q4 | $340K | Buy |
3,402
+2,611
| +330% | +$255K | 0.02% | 280 |
|
|
2015
Q3 | $72K | Sell |
791
-11,480
| -94% | -$1.15M | 0.01% | 293 |
|
|
2015
Q2 | $1.3M | Buy |
+12,271
| New | +$1.36M | 0.1% | 230 |
|
Other funds holding ZBH
Tredje AP-fonden's ZBH Position: Q2 2026 in Review
Tredje AP-fonden increased its Zimmer Biomet (ZBH) stake by 45% in Q2 2026, buying an estimated $3.21M and bringing the position to 117,984 shares worth $10.2M. The position accounts for 0.05% of the portfolio, ranked #325.
Tredje AP-fonden first reported a position in ZBH in Q2 2015 and has held it in 45 quarters since. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Tredje AP-fonden held 117,984 shares of Zimmer Biomet worth $10.2M as of Q2 2026.
- Tredje AP-fonden bought 36,634 Zimmer Biomet shares in Q2 2026, an estimated $3.21M.
- Zimmer Biomet made up 0.05% of Tredje AP-fonden's portfolio in Q2 2026, its #325 holding.
- Tredje AP-fonden first reported a position in Zimmer Biomet in Q2 2015 and has held it in 45 quarters since.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Tredje AP-fonden's 13F filing for Q2 2026, filed 10 Aug 2026.